Relay Therapeutics upgraded to Outperform: zovegalisib PI3Kα breast cancer catalyst, $596M cash to 2029, Phase 3 mid-2026.
Scientists have launched a fresh effort to find out what could be producing oxygen at the bottom of the Pacific Ocean.